Pneumococcal conjugate vaccine (PCV) 2024

Description

The provision of a vaccine to protect against invasive Pneumococcal disease, to be used as part of the national childhood immunisation programme. The contracting authority estimates their requirement over the period of the contract, including the period of the optional extension to be up to 6.47 million doses of vaccine. Deliveries will be required over a period of 2 years, with an option to extend for up to an additional 24 months. The opportunity is not split into lots as an award to more than one supplier would not be operationally viable for this vaccination programme. Additional information: To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome. Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at: Phone: 0800 9956035 E-mail: support-health@atamis.co.uk

Related Contracts